| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 07/29/2003 | US6600013 Moraxella catarrhalis BASB034 polypeptides and uses thereof |
| 07/29/2003 | US6599909 Transfection of tumor by an adenovirus encoding a cytosine deaminase gene, administering a dose of 5-fluorocytosine to said individual, treating said individual with a single or multiple fractions of radiation |
| 07/29/2003 | US6599879 Therapeutic uses of keratinocyte growth factor-2 |
| 07/29/2003 | US6599744 Expression vector for use as tool in the transfer nucleotide sequences and generation of heterologous proteins in cells |
| 07/29/2003 | US6599742 Antisense oligonucleotide inhibition of human serine/threonine protein phosphatase gene expression |
| 07/29/2003 | US6599741 Modulating transcription of genes in vascular cells |
| 07/29/2003 | US6599739 Papillomavirus viral vector for use in the transfer of nucleotide sequences |
| 07/29/2003 | US6599737 Adenoviral vectors with tandem fiber proteins |
| 07/29/2003 | US6599719 For therapy of rheumatoid arthritis, tumors |
| 07/29/2003 | US6599699 Methods for diagnosing a disorder by assaying for MAGE-3 |
| 07/29/2003 | US6599698 Mutated steroid hormone receptors, methods for their use and molecular switch for gene therapy |
| 07/29/2003 | US6599695 Method for assaying for early gene expression in neuroblasts |
| 07/29/2003 | US6599527 Preparation of pharmaceutical compositions |
| 07/29/2003 | US6599495 Nucleotide and protein sequence of mammastatin and methods of use |
| 07/29/2003 | CA2269502C Tetraether lipid derivatives and liposomes and lipid agglomerates containing tetraetherlipid derivatives, and use thereof |
| 07/29/2003 | CA2210444C Keratinocyte growth factor-2 |
| 07/29/2003 | CA2094280C A method for transplanting cells into the brain and therapeutic uses therefor |
| 07/29/2003 | CA2093664C Modified ribozymes |
| 07/29/2003 | CA2060489C Diagnosis and treatment of neuro-cognitive disorders associated with systemic immunological malfunction |
| 07/24/2003 | WO2003060149A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 07/24/2003 | WO2003060147A2 Method of obtaining purified enterochromaffin cells and methods of using same |
| 07/24/2003 | WO2003060142A2 Compositions and methods for controlled release |
| 07/24/2003 | WO2003060126A1 Rheumatoid arthritis disease sensitive gene, its protein, method and kit of judging the onset of rheumatoid arthritis using the same, and method and drugs for treating rheumatoid arthritis |
| 07/24/2003 | WO2003060121A2 Compositions and methods relating to gastric specific genes and proteins |
| 07/24/2003 | WO2003060101A2 Gene delivery system and methods of use |
| 07/24/2003 | WO2003060096A2 Assay for the detection of factors that modulate the expression of ingap |
| 07/24/2003 | WO2003059952A1 Bispecific antibody dna constructs for intramuscular administration |
| 07/24/2003 | WO2003059950A1 Ifnar2 mutants, their production and use |
| 07/24/2003 | WO2003059948A1 Dilated cardiomyopathy associated gene-2 (dcmag-2): a cytoplasmatic inducer of sarcomeric remodeling in cardiomyocytes |
| 07/24/2003 | WO2003059940A1 Biomolecule transduction motif sim-2-btm and the use thereof |
| 07/24/2003 | WO2003059938A1 Chromatin remodeling protein as a marker expressed by stromal progenitor cells |
| 07/24/2003 | WO2003059932A2 Methods of inducing or enhancing connective tissue repair |
| 07/24/2003 | WO2003059927A1 Compositions and methods relating to endometrial specific genes and proteins |
| 07/24/2003 | WO2003059396A1 Adiponectin gene therapy |
| 07/24/2003 | WO2003059395A2 Antisense compounds directed against human csf-1 |
| 07/24/2003 | WO2003059382A2 Pharmaceutical compositions comprising polyanionic polymers and amphiphilic block copolymers and methods of use thereof to improve gene expression |
| 07/24/2003 | WO2003059381A2 Immunogenic preparations and vaccines on the basis of mrna |
| 07/24/2003 | WO2003059376A1 The use of il6r/il6 chimera in nerve cell regeneration |
| 07/24/2003 | WO2003059290A2 Diagnostic and therapeutic uses of topors |
| 07/24/2003 | WO2003059268A2 A novel germ cell-specific contraceptive target |
| 07/24/2003 | WO2003059262A2 Method and composition for treating and preventing hiv infection and aids |
| 07/24/2003 | WO2003059153A2 Composition and imaging methods for pharmacokinetic and pharmacodynamic evaluation of therapeutic delivery system |
| 07/24/2003 | WO2003045999A3 Human vanilloid receptor protein and polynucleotide sequence encoding same |
| 07/24/2003 | WO2003006645A3 Method and composition for inhibiting heparanase activity |
| 07/24/2003 | WO2003004526B1 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or resistance to viruses and their use as medicines |
| 07/24/2003 | WO2002099057A3 Sams modifiers of the p53 pathway and methods of use |
| 07/24/2003 | WO2002077156A3 Protection-of-telomere-1 (pot-1) protein and encoding polynucleotides |
| 07/24/2003 | WO2002074807A3 Chimpanzee erythropoietin (chepo) - immunoadhesins |
| 07/24/2003 | WO2002059338A3 Retroviral vectors for transduction into quiescent cells and packaging systems for them |
| 07/24/2003 | WO2002057480A3 Cell-proliferative disorder treatments using cre decoy oligomers, bcl-2 antisense and hybrid oligomers |
| 07/24/2003 | WO2002053770A3 Method for the prediction of the risk potential for cancerous diseases and inflammatory intestinal diseases and corresponding tests |
| 07/24/2003 | WO2002050278A3 Novel human secreted proteins and polynucleotides encoding the same |
| 07/24/2003 | WO2002049669A3 Electrically responsive promoter system |
| 07/24/2003 | WO2002036634A3 Gene regulation therapy involving ferritin |
| 07/24/2003 | WO2002018954A3 Inhibition of cmv infection and dissemination |
| 07/24/2003 | WO2002006537A3 Methods of identifying renal protective factors |
| 07/24/2003 | US20030140376 Optimized t-dna transfer and vectors therefor |
| 07/24/2003 | US20030140359 Non-human mammals comprising cells expressing vector-borne rat PTTG carboxy-terminal-related DNA |
| 07/24/2003 | US20030139591 Isolation and use of tissue growth-inducing Frzb protein |
| 07/24/2003 | US20030139590 Comprises nucleotide sequences coding orphan receptor 25 for detecting modulators of platelet activating factor (PAF) activity; antiinflammatory agents; gene/translation inhibition; drug screening |
| 07/24/2003 | US20030139585 Oligonucleotide derivatives which are at least partly double-stranded and which have a 2'5'-linked oligonucleotide residue on at least one 3' end; use in formulating pharmaceutical for tumor therapy, infectious diseases |
| 07/24/2003 | US20030139584 Tumor necrosis factor Receptor-Associated Factor (TRAF) protein-interacting hereditary multiple extoses (TREX) for use in the diagnosis and treatment of cancer and autoimmune disorders; antitummor agents |
| 07/24/2003 | US20030139367 Gene therapy composition for treating viral myocarditis |
| 07/24/2003 | US20030139365 Expression and export of angiogenesis inhibitors as immunofusins |
| 07/24/2003 | US20030139364 Methods and products for enhancing immune responses using imidazoquinoline compounds |
| 07/24/2003 | US20030139363 Methods and compositions for RNAi mediated inhibition of viral gene expression in mammals |
| 07/24/2003 | US20030139361 Organ grafting; antiinflammatory agents, autoimmune disease |
| 07/24/2003 | US20030139335 Diagnosis of premature infants; collagen forming |
| 07/24/2003 | US20030139334 Cell cycle controlling protein; vaccines |
| 07/24/2003 | US20030139333 Methods and compositions for promoting angiogenesis |
| 07/24/2003 | US20030139330 Transcription factors containing two potential dna binding motifs |
| 07/24/2003 | US20030139328 Complexing; modulating biological activation |
| 07/24/2003 | US20030139327 Nucleic acids, proteins, and antibodies |
| 07/24/2003 | US20030139325 Complex comprising OCIF and polysaccharide |
| 07/24/2003 | US20030139324 Cancer diagnosis, therapy; genetic engineered polypeptide |
| 07/24/2003 | US20030138955 Delivering nucleotide sequences coding myogenin protein for improving angiogenesis and/or neovascularisation; skin grafting; tissue engineering; wound healing agents; gene therapy |
| 07/24/2003 | US20030138954 Self-inactivating plasmid/vector; gene therapy; treating hematological disorders; anticarcinogenic agents |
| 07/24/2003 | US20030138948 Pluripotent pancreatic tissue for generating differentiated islets of langerhans; drug screening; regeneration medicine; antidiabetic agents |
| 07/24/2003 | US20030138947 Using cyclophosphoamide to retrodifferentiate hemopioetic cells into pluripotent stem cells and redifferentiate them into myleoid cells; treating immunological disorders; anticarcinogenic agents |
| 07/24/2003 | US20030138946 Genetically engineered major histocompatibiity complex antigen presenting cells for activating CD8 lymphocytes and producing cytokines and becoming cytotoxic; antitumor agents |
| 07/24/2003 | US20030138926 Novel polynucleotides and polypeptides encoded thereby |
| 07/24/2003 | US20030138925 Novel human gene relating to respiratory diseases, obesity, and inflammatory bowel disease |
| 07/24/2003 | US20030138884 APRIL- a novel protein with growth effects |
| 07/24/2003 | US20030138833 Psoriasin expression by breast epithelial cells |
| 07/24/2003 | US20030138815 Cyclic adenosine monophosphate (cAMP); drug screening; bronchodilators; antiinflammatory agents; immunomodulators; antiallergens; bioassays |
| 07/24/2003 | US20030138795 Polynucleotide encoding a novel human growth factor with homology to epidermal growth factor, BGS-8, expressed highly in immune tissue |
| 07/24/2003 | US20030138793 Kit for identifying the origin of tumors in prostate, breast, colorectal, lung, ovarian, gastroesophageal, pancreatic, liver, kidney or bladder cells by way of probes for analyzing marker gene expression |
| 07/24/2003 | US20030138772 Polymerase chain reactions to screen and isolate parvovirus DNA obtained from tissue and/or cells without coinfection by helper viruses; gene therapy |
| 07/24/2003 | US20030138458 HCV E1E2 vaccine compositions |
| 07/24/2003 | US20030138457 Such as F protein of Paramyxovirus SV5 strain; this recombinant Rhabdovirus may express other non-Rhabdovirus attachment proteins and/or an enhancer protein; for diagnostic and therapeutic compositions for treatment of diseases |
| 07/24/2003 | US20030138453 Microparticles comprise a polymer such as a poly(alpha-hydroxy acid), polyhydroxy butyric acid, polycaprolactone, a polyorthoester, a polyanhydride, formed using cationic, anionic, or nomonic detergents; drug delivery |
| 07/24/2003 | US20030138444 Composition and method for treating HIV infection |
| 07/24/2003 | US20030138441 A polynucleotide sequence which encodes a Dermatophagoides dust mite protein, wherein the codon usage pattern of the polynucleotide sequence resembles that of highly expressed mammalian genes |
| 07/24/2003 | US20030138429 Compositions and methods for inhibiting metastasis |
| 07/24/2003 | US20030138414 Modulators of methylation for control of bacterial virulence |
| 07/24/2003 | US20030138412 Inhibition of tumor growth and metastasis by N5 gene |
| 07/24/2003 | US20030138410 Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells |
| 07/24/2003 | US20030138407 Therapeutic methods for nucleic acid delivery vehicles |
| 07/24/2003 | US20030138405 An adenovirus encoding an E1A polypeptide unable to bind the tumor suppressor protein retinoblastomas (Rb) may replicate in or kill a cell having a defective Rb pathway but not the non-mutant cells; gliomas; gene therapy; antitumor agents |
| 07/24/2003 | CA2474138A1 Composition and imaging methods for pharmacokinetic and pharmacodynamic evaluation of therapeutic delivery system |